APP and Down syndrome: Compared to control samples, platelets and fibroblasts from individuals with Down syndrome exhibit marked decreases in glutamate uptake (Begni et al., 2003), which alteration was attributed to beta-amyloid aggregation, mitochondrial dysfunction, and amyloid precursor protein overexpression (Begni et al., 2003).